MML Investors Services LLC Decreases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

MML Investors Services LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,901 shares of the financial services provider’s stock after selling 1,511 shares during the period. MML Investors Services LLC owned approximately 0.13% of iShares Biotechnology ETF worth $9,450,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Williams Financial LLC bought a new position in iShares Biotechnology ETF during the 2nd quarter valued at about $867,000. PVG Asset Management Corp bought a new position in shares of iShares Biotechnology ETF during the second quarter valued at approximately $415,000. Huntington National Bank raised its holdings in shares of iShares Biotechnology ETF by 17.9% in the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after buying an additional 160 shares during the period. Concourse Financial Group Securities Inc. raised its holdings in shares of iShares Biotechnology ETF by 22.4% in the second quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock worth $90,000 after buying an additional 120 shares during the period. Finally, Raymond James & Associates boosted its holdings in iShares Biotechnology ETF by 4.4% during the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after acquiring an additional 7,931 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.8 %

Shares of iShares Biotechnology ETF stock opened at $140.56 on Wednesday. iShares Biotechnology ETF has a 52 week low of $123.56 and a 52 week high of $150.57. The stock’s fifty day moving average is $142.18 and its two-hundred day moving average is $142.29.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.